Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liraglutide for Cognitive Function in Type 2 Diabetes
NCT05360147Phase 3Completed
- Sponsor
- Army Medical University
- Start
- Jan 2021
- Primary completion
- Apr 2021
- Modality
- Peptides
- Countries
- 1
01
Overview
A Phase 3 trial of liraglutide in cognitive impairment, sponsored by Army Medical University. Started Jan 2021; status: completed.
02
Drugs
03
Conditions
cognitive impairment
Beyond the preview
Go deeper on NCT05360147.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05360147.